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SUMMARY
Hepatic venous outflow obstruction (HVOO) is a rare complication after
liver transplantation (LT) associated with significant morbidity and
reduced graft survival. Endovascular intervention has become the first-line
treatment for HVOO, but data on long-term outcomes are lacking. We
have analysed outcomes after endovascular intervention for HVOO in 905
consecutive patients who received 965 full-size LT at our unit from Jan-
uary 2007 to June 2014. There were 27 (3%) patients who underwent hep-
atic venogram for suspected HVOO, with persistent ascites being the most
common symptom triggering the investigation (n = 19, 70%). Of those,
only 10 patients demonstrated either stricture or pressure gradient over
10 mmHg on venogram, which represents a 1% incidence of HVOO. The
endovascular interventions were balloon dilatation (n = 3), hepatic vein
stenting (n = 4) and stenting with dilatation (n = 3). Two patients
required restenting due to stent migration. The symptoms of HVOO com-
pletely resolved in all but one patient, with a median follow-up period of
74 (interquartile range 39–89) months. There were no procedure-related
complications or mortality. In conclusion, the incidence of HVOO in
patients receiving full-size LT is currently very low. Endovascular interven-
tion is an effective and safe procedure providing symptom relief with long-
lasting primary patency.
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Introduction
Liver transplantation (LT) is the treatment of choice for
patients with end-stage chronic liver disease, early stages
of liver cancer and fulminant hepatic failure. Over the
past 4 decades, the surgical technique has evolved sig-
nificantly, with a concomitant fall in morbidity and
mortality [1]. Initially, LTs were performed using caval
replacement, but this was associated with hemodynamic
instability [2,3]. Calne and Williams first introduced




caval preservation in 1968, and this was reintroduced
20 years later and termed ‘piggyback’ technique and has
gained widespread acceptance [4–6].
Hepatic venous outflow obstruction (HVOO), so-
called piggyback syndrome, is a rare but potentially
lethal complication after LT [7–10]. HVOO is more
commonly associated with use of partial liver grafts,
with a reported incidence between 1.5% and 4% com-
pared to a rate of 1% after full-size LT [11–15]. HVOO
can occur in the early postoperative period, possibly
from direct compression of the hepatic veins, but can
also occur several months to years later from fibrotic
changes at the anastomosis [16–18].
Hepatic venous stenosis presents with ascites, variceal
haemorrhage, splenomegaly and abnormal liver and kid-
ney function [19]. Early detection of HVOO is impor-
tant as the liver graft dysfunction can result from
congestion, and timely intervention such as balloon
angioplasty or stent placement can preserve graft func-
tion [11,20–23]. Long-term follow-up data after
endovascular treatment for HVOO are lacking. We pre-
sent the long-term follow-up of our experience with
management of HVOO in a large single centre series.
Patients and methods
Study design and patients
Retrospective analysis of a prospectively maintained
database of patients who had liver transplantation at the
Liver Unit in Birmingham between 1 January 2007 and
30 June 2014 was performed. The start of the study per-
iod coincided with the transition from film-based to
digital-based imaging in our radiology department.
There were a total of 1086 liver transplant procedures
performed on 1026 patients. One hundred and twenty-
one procedures were performed with partial grafts (116
right lobe grafts and 5 left lobe grafts, including 7 live
donor liver transplants). These patients were excluded
from the study. Nine hundred and five patients who
received full-size liver grafts were included in our study.
From this cohort, we identified patients who developed
symptoms suspicious of HVOO and collected their
demographic details, indication for liver transplantation,
clinical presentation of suspected HVOO, venograms
and details of endovascular interventions. Data regard-
ing symptom relief were collected during clinic follow-
up appointments and the date of last follow-up in this
study was 31 March 2016. A range of donor- and
organ-related factors were compared between those
patients that did and did not develop HVOO. Overall
patient and graft survival and survival with and without
HVOO were compared.
The primary study endpoints were resolution of
symptoms and post-transplant survival. Any stent-
related complications were recorded according to Cla-
vien-Dindo classification [24]. The procedure-related
death was defined as any mortality within 90 days fol-
lowing the intervention.
Surgical technique of the hepatic venous outflow
reconstruction
Liver transplants were performed by a team of eight
transplant surgeons using piggyback technique. The unit
changed from the inferior vena cava (IVC) replacement
to piggyback implantation technique in 2000. The tech-
nical detail of the piggyback technique and its modifica-
tions are shown in Fig. 1. Six surgeons performed
modified piggyback implantation as popularized by Bel-
ghiti, with both ends of the IVC closed and large side-
to-side caval anastomosis (variant 1) [5]. One surgeon
each performed side-to-side cavocavostomy with upper
open end of the IVC included in the anastomosis (vari-
ant 2) and classical technique creating anastomosis
between the suprahepatic part of the donor IVC and
the common orifice of left and middle hepatic veins
(variant 3) [25]. With all approaches, the native IVC
flow was maintained throughout the implantation per-
iod.
The anastomosis was performed with a continuous,
nonabsorbable polypropylene 4-0 suture (Prolene; Ethi-
con Inc., Livingston, UK). In the case of the longitudi-
nal cavocavostomy, the recipient IVC venotomy was
performed as close to the diaphragm as technically fea-
sible, usually placing the upper corner of the anastomo-
sis above the level of the native hepatic veins (Fig. 2).
For the side-to-side technique, with both ends of the
donor IVC closed, the graft venotomy was positioned as
close to the suprahepatic IVC suture line as possible.
Post-transplant immunosuppression and follow-up
Post-transplant immunosuppression consisted of tacroli-
mus-based therapy in combination with either azathio-
prine or mycophenolate mofetil, and a 3-month course
of prednisolone. All patients received aspirin 75 mg
daily as standard long-term prophylaxis of hepatic
artery thrombosis.
After discharge from hospital, patients were followed
up on a weekly (first 6 weeks) then fortnightly (after
6 weeks) basis until 3 months after transplantation.
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Each outpatient consultation consisted of a clinical
review and blood analysis including liver function tests.
Hepatic venous outflow obstruction diagnosis and
interventions
The clinical symptoms triggering the suspicion of
HVOO were persistent ascites, lower extremity oedema,
pleural effusion and deranged liver function. All
patients with any of those symptoms underwent Dop-
pler liver ultrasound and subsequently hepatic venogra-
phy, performed through transjugular approach in all
patients. All patients diagnosed with HVOO on hepatic
venography (slow flow across the anastomosis, pressure
gradient greater than 10 mmHg across the anastomosis
and stenosis at the anastomosis) were treated with
Figure 1 Study inclusion flow chart.
Figure 2 Technical aspects and variants of the piggyback anastomosis. The figure highlights technical aspects of the piggyback hepatic venous
outflow reconstruction. (Panel a) Demonstrates back-table preparation of the graft inferior vena cava (IVC) with the divided retrocaval liga-
ment, exposing the posterior aspect of the retrohepatic IVC; this preparation is not necessary for the conventional piggyback technique (see
below). (Panel b) Shows the incision in the posterior aspect of the suprahepatic IVC and orifices of all the three hepatic veins. (Panel c) Displays
the recipient IVC after the native liver hepatectomy, the stump of the right hepatic vein divided with an endo-GIA vascular stapler in the longi-
tudinal direction and the stump of the left and middle hepatic veins in the transverse direction close to the diaphragm. (Panel d) Illustrates the
Babcock clamps used to apply traction on the anterior aspect of the IVC wall to facilitate placement of a large Satinsky clamp as demonstrated
in (Panel e), preserving approximately 50% of the vascular flow. (Panel f) Displays the longitudinal venotomy with placed stay sutures in prepa-
ration for the side-to-side venoplasty. (Panel g) Shows a suture in the inferior and (Panel h) a suture in the superior corners of the donor IVC.
(Panel i) Demonstrates the sutured right side of the caval anastomosis. (Panel j) Shows the right-side lateral view of the implanted liver graft.
(Panel k) Shows the recipient IVC opening used to perform side-to-side modified (left) or end-to-side traditional piggyback anastomosis.
(Panel l) Displays the lateral view of the postimplantation anatomical situation in variants 1 (top) and 2 (middle) of side-to-side cavostomy; the
bottom drawing shows traditional piggyback anastomosis of the donor suprahepatic IVC to the orifices of the left and middle hepatic veins.
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venoplasty with 10- to 12-mm balloon initially. If the
pressure gradient was persistently high and/or residual
stenosis was present even after venoplasty on check
venogram, then they were treated with a 10- to 12-
mm self-expanding uncovered stent (Boston Scientific
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Patients who had persistent symptoms postprocedure
were subjected to repeat venogram. Again during the
second venogram, venoplasty was initially attempted,
but patients with high pressure gradient and/or resid-
ual stenosis after venoplasty were stented. Two experi-
enced interventional liver radiologists performed all
interventions and the findings were discussed at a mul-
tidisciplinary liver transplant meeting. Patients who
had no evidence of HVOO on hepatic venography
were treated with diuretics rather than endovascular
therapy.
Statistical analysis
Continuous variables were presented as median with
interquartile range and the categorical variables were
presented as numbers and percentages. Survival was cal-
culated using Kaplan–Meier method. Univariate analysis
was performed to assess the relationship between
HVOO and various donor- and graft-related factors.
SPSS software (version 22.0; SPSS Inc., Chicago, IL,
USA) was used to perform statistical analysis. For pre-
senting the results, percentages were rounded to whole
numbers and p-values to three decimals.
Results
A total of 905 patients received 965 full-size graft trans-
plants over the study period. Among these, 60 were
retransplantations for various indications, but none of
the retransplants were performed for HVOO. Only 27
(3%) patients developed symptoms suggestive of
HVOO. These cases constituted the presented series
cohort and are shown in Table 1. Caval anastomosis
was performed as variant 1 in 751, variant 2 in 97 and
variant 3 in 117 patients (Fig 2.). Among the symp-
tomatic patients, twenty-six patients had caval recon-
struction with side-to-side cavostomy (variant 1) and
one patient had the donor suprahepatic IVC reconstruc-
tion to the recipient left and middle hepatic veins (vari-
ant 3; this patient did not have proven HVOO on
venogram) (Table 2).
The median time between transplantation and devel-
opment of symptoms suggestive of HVOO was 3 [in-
terquartile range (IQR) 1.7–6.9] months, with the
overall follow-up period of 101 months. The most com-
mon presenting symptom was ascites (n = 19, 70%).
Other symptoms suggestive of HVOO were deranged
liver function (n = 5), lower extremity oedema (n = 5),
pleural effusion (n = 3) and two patients had evidence
of venous congestion on liver biopsy. These symp-
tomatic patients underwent percutaneous hepatic veno-
gram with pressure measurements in right atrium, IVC
and hepatic veins. Ultrasound findings suggestive of
HVOO (disappearance of pulsatile hepatic venous out-
flow or flattening of the hepatic venous waves) were
present only in 4 of our 27 (15%) patients. Liver biopsy
findings of HVOO were congestion, haemorrhage and




HVOO (n = 27)
Patients with proven
HVOO (n = 10)
Fulminant hepatic failure* 100 4 2
Hepatocellular carcinoma† 164 1 2
Hepatitis C Virus 91 3 0
Primary biliary cirrhosis 102 3 0
Primary sclerosing cholangitis 89 2 1
Alcohol-related liver disease 150 2 1
Autoimmune hepatitis 25 2 1
Budd–Chiari Syndrome 8 2 1
Alpha-1 antitrypsin deficiency 13 2 1
Nonalcoholic steatohepatitis 40 2 0
Nodular regenerative hyperplasia 12 1 0
Polycystic liver disease 20 1 0
Cryptogenic cirrhosis 22 1 0
Retransplantation† 60 1 1
Others 69 0 0
HVOO, hepatic venous outflow obstruction.
*Indication included fulminant liver failure caused by paracetamol overdose, seronegative and drug-induced hepatitis.
†Various aetiology or indication.
1110 Transplant International 2016; 29: 1106–1116
ª 2016 Steunstichting ESOT
Pitchaimuthu et al.
necrosis around the central veins, and were present in
two patients (7%). Only 10 of the 27 (37%) patients
with symptoms concerning for HVOO had a hepatic
venous pressure gradient greater than 10 mmHg or
venogram suggestive of stricture and all these patients
had side-to-side cavocavostomy anastomosis. This yields
an overall incidence of HVOO in our series of 1.1%.
Among the 10 patients with positive venogram, three
patients who had high pressure gradient or stenosis at
the anastomosis were treated only with hepatic veno-
plasty (Fig. 3). Four patients with persistent high pres-
sure gradient, even after venoplasty on check venogram,
were treated with hepatic venous stenting during the
index venogram (Fig. 4). Three patients were treated
initially with hepatic venoplasty, but, due to persistent
symptoms and pressure gradient/residual stenosis on a
subsequent venogram even after repeat venoplasty, they
underwent hepatic vein stenting. In all patients, pressure
gradient of <10 mmHg and/or disappearance of stenosis
was confirmed with postvenoplasty/stenting venograms.
The median post-transplant and postprocedure follow-
up periods were 76 (IQR 54–91) months and 74 (IQR
39–89) months, respectively.
In all patients in the intervention group, the symp-
toms of HVOO resolved completely. Of two patients in
this group who had deranged liver function tests along
with other symptoms of HVOO before the procedure, 1
had stenting and the liver function became normal dur-
ing follow-up, and one patient had hepatic venoplasty
and was scheduled to undergo stenting, but was lost to




HVOO (n = 27)
Patients with proven
HVOO (n = 10)
Piggyback surgical reconstruction
Variant 1 751 26 10
Variant 2 97 0 0
Variant 3 117 1 0
1-year graft survival 86% 100% 100%
5-year graft survival 76% 82% 70%
1-year patient survival 90% 100% 100%
5-year patient survival 79% 87% 80%
HVOO, hepatic venous outflow obstruction.
(a) (b)
Figure 3 Venogram of a patient with hepatic venous outflow obstruction. Hepatic venogram shows narrowing at the anastomosis level
(Panel a) treated with balloon venoplasty demonstrates resolved stenosis (Panel b).
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follow-up due to noncompliance and this patient died
28 weeks later from opioid overdose and noncompli-
ance with immunosuppression.
During follow-up, two patients were found to have
stent migration, requiring restenting, and one patient
had repeated balloon dilatation for persistent ascites
(Fig. 4). There was no procedure-related mortality in
our series. Of the patients who underwent intervention
for HVOO, two patients died during follow-up from
causes unrelated to HVOO (meningioma and chronic
rejection after a 4th LT).
Of the 17 patients with symptoms of HVOO but no
HV pressure gradient or venogram findings suggestive
of HVOO (and therefore no intervention performed),
two patients died. One of these patients died from
squamous cell carcinoma of the ear and the other from
hepatitis C recurrence.
On univariate analysis, donor-related factors (donor
age, height, weight and BMI) and graft-related factors
(cold ischaemic time, graft steatosis, surgeons’ pretrans-
plant assessment about the graft) were analysed
between patients with and without HVOO. None of
these comparisons were found to be significant
(Table 3). However, due to the small sample size in
the HVOO group, the statistical power of this analysis
was low. Overall patient survival and graft survival
were calculated for the whole study period. Patient sur-
vival and graft survival were compared separately for
patients with and without HVOO. (Table 2 and
Fig. 5).
(a) (b)
Figure 4 Venogram of a patient undergoing hepatic venous outflow stenting. The figure shows hepatic venogram with narrowing at the anas-
tomosis level prior (Panel a) and after (Panel b) the stent insertion.
Table 3. Risk factors for hepatic venous outflow obstruction.
HVOO
P-valueNo (n = 895) Yes (n = 10)
Donor age (years) 50  15 50  15 1.000
Donor height (cm) 169  11 171  10 0.523
Donor weight (kg) 75  15 79  10 0.441
Body mass index (kg/m2) 26  5 27  4 0.644
Cold ischaemic time (min) 487  135 555  117 0.113
Steatosis 75 (8%) 1 (10%) 0.586
Suboptimal organ 283 (32%) 1 (10%) 0.185
HVOO, hepatic venous outflow obstruction.
Data reported as mean  standard deviation with P-values from t-tests, or N (%) with P-value from Fisher’s exact test, as
applicable. This analysis includes only 905 patients who received primary transplant with full-size graft.
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Discussion
Hepatic venous outflow obstruction due to anastomotic
stricture is a very rare complication after liver trans-
plantation in adult recipients who receive full-size liver
grafts in a piggyback technique [26]. HVOO early after
liver transplantation is associated with high morbidity
and mortality; almost one-third of patients will require
retransplantation if surgical and endovascular interven-
tions fail [27,28]. HVOO occurring in the early postop-
erative period is thought to be secondary to several
factors, such as a tight suture line, kinking of a redun-
dant hepatic vein, donor–recipient size discrepancy or
caval compression from a large graft [14]. HVOO
occurring after the first 3 months is thought to arise
from fibrosis of the anastomotic site and intimal hyper-
plasia [14]. Vilca et al. [29] reported that caval replace-
ment technique has the advantages of wider
retrohepatic cava which avoids venous outflow or caval
obstruction.
The existing literature describes an incidence of
HVOO after full-size graft liver transplantation between
0.8% and 1% concurrent with our incidence of 1%
[22,28]. It is well documented that the incidence of
HVOO is higher in patients receiving partial liver grafts,
ranging between 3.9% and 16.6% [13,21,23,30]. This is
likely due to the fact that the anastomosis of the hepatic
veins to the IVC in partial grafts is smaller [31,32].
Additionally, partial liver grafts usually grow consider-
ably after transplantation, so the hepatic venous outlet
might be compromised by distortion of the outlet
[26,33].
Patients with hepatic venous outflow obstruction
usually present with large volume ascites, which is
refractory to diuretic therapy and protein supplementa-
tion, and bilateral lower limb oedema [22,28]. Clinically
significant early post-transplant HVOO usually causes
deterioration of liver and renal function. In some
patients, HVOO can also cause symptoms including
ascites and renal dysfunction without deterioration of
hepatic function [34]. In either case, early treatment of
HVOO is critical to prevent morbidity and mortality
[35–37].
In our series, the most commonly described symptom
was ascites, present in 76% of our patients with sus-
pected HVOO, but 27% of patients with a positive
venogram. Deranged liver function, lower extremity
oedema and pleural effusions are some of the other
symptoms in our series. In two patients, liver biopsy
demonstrated evidence of hepatic venous congestion,
leading to an eventual diagnosis of HVOO.
Doppler ultrasound is a useful screening test in
patients suspected of having HVOO, when a dampened
waveform with decreased mean velocity in the hepatic
veins is seen [38]. If significant stenosis develops, the
waveform usually degrades to a monophasic pattern,
and in some cases reversal of flow in the hepatic veins
can be demonstrated [39–41]. Reduced pulsatility is
associated with transplant hepatic vein stenosis [42].
The venous pulsatility index, described by Coulden
et al. and Chong et al. [43,44], can be used to increase
the specificity of Doppler ultrasound.
Venography and measurement of pressures within
the hepatic veins is the confirmatory test of choice in
patients suspected of having HVOO [19,45]. There is
no consensus on the hepatic vein pressure gradient that
is significant in a patient suspected of having HVOO,
and pressure gradients from 3 to 20 mmHg have been
reported as the threshold of clinical significance [40]. A
gradient greater than 10 mmHg between the hepatic
vein and the right atrium is most commonly used for
the diagnosis of HVOO [11,46]. In our study, the
Figure 5 Patient and graft survival. (Panel a) Demonstrates the Kaplan–Meier curves with the overall patient (full line) and graft (dotted line)
survivals of all 965 full-size liver transplant recipients transplanted over the study period. (Panel b) Shows the overall survival of patients without
(blue line), respective with proven (red line) hepatic venous outflow obstruction. (c) Shows the graft survival in the same groups of patients.
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presence of HVOO symptoms with a gradient of
10 mmHg and/or stricture on venogram was an indica-
tion for intervention.
Therapeutic options for HVOO include angioplasty
with or without stent placement, surgical reconstruction
of the venous anastomosis and retransplantation [47].
Hepatic venous outflow obstruction immediately after
transplantation can be treated with surgical revision of
the HV anastomosis [23,47,48]. Conversely, late-onset
hepatic venous outflow obstruction produces insidious
deterioration of liver and kidney function, and surgical
correction is difficult; thus, endovascular interventions
are preferred [15,49–52].
In our series, there were no patients with early
HVOO requiring reoperation or retransplantation. The
median duration between liver transplantation and the
development of symptoms requiring venogram was
3 months. This was considered late-onset HVOO and
was treated with venoplasty and/or stenting.
Ten of the 27 patients with suspected HVOO had a
pressure gradient over 10 mmHg and/or stricture at the
anastomosis. All of these patients were initially treated
with balloon dilatation, unless there was a persistent high
pressure gradient on the check venogram. In such cases, a
stent was placed during the index venogram (n = 4).
Hypotension, arrhythmia, stent occlusion, restenosis and
stent migration are some reported complications of hep-
atic vein stents [33]. In our study, two out of seven
patients who were stented developed stent migration
requiring a second stent. None of our patients developed
a procedure-related complication. Symptoms resolved in
all treated patients, except the patient who did not attend
the appointment for stent placement.
Repeated balloon dilatation or stent placement after
the venoplasty may be required for persistent symptoms
of HVOO and high pressure gradient or recurrent
stenosis. In our study, one patient required a second
balloon dilatation, and three patients required stenting
after dilatation. For refractory cases, formal reconstruc-
tion of outflow may be required. Quintini et al. [47]
suggested a side-to-side cavostomy using GIA stapler.
There was no need for any surgical intervention in our
patients for HVOO.
The literature describing the management of HVOO
after full-size graft liver transplantation is dominated by
case reports [53]. Most of the available literature on
HVOO is from experiences in living donor transplanta-
tion [33]. Quintela et al. [31] reported their experience
with end-to-side cavocavostomy for early hepatic
venous outflow obstruction with 45-month follow-up,
but there are no reports of long-term follow-up after
endovascular intervention. With the median follow-up
of 74 months and maximum overall follow-up of
101 months, none of our patients required surgical
intervention for HVOO, indicating that the combina-
tion of balloon angioplasty and/or stenting has long-
term success in the management of HVOO.
On further analysis, no risk factors have been identi-
fied that may be related to development of this compli-
cation. In accordance with previous reports, we
observed perhaps more cases with HVOO in patients
transplanted for Budd–Chiari syndrome [54,55]. The
relatively higher incidence in patients undergoing liver
retransplantation might be explained by the technical
aspects of the challenging procedure, with possible kink-
ing or twisting of the IVC anastomosis, performed usu-
ally on the IVC cuff remaining from the failed graft.
For the recipients with fulminant liver failure, we can
speculate that HVOO might be related to cases when
the procedure urgency might have led to usage of size-
mismatched organs, with a relatively large graft com-
pressing the venous outflow. It would be interesting to
perform prospective analyses to detect factors associated
with HVOO, which could be used to identify patients at
risk of the complication. The inability to perform this
represents a limitation of this report, but due to the
infrequency of HVOO occurrence, this would require a
large, multicentre transplant registry study to collect a
sufficient sample size to attain adequate statistical power
for the detection of clinically relevant associations.
We conclude that the incidence of HVOO in patients
receiving full-size liver transplantation is 1%. Endovas-
cular intervention is effective with negligible procedure-
related morbidity. The median follow-up period of
74 months after treatment demonstrates that endovas-
cular treatments provide symptom relief with long-last-
ing primary patency, with only three patients requiring
repeated interventions.
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